鼻整形文献评点 · Rhinoplasty Daily Commentary
鼻整形鼻通气前瞻性
Aesthetic Plastic Surgery · PMID 43007373 ·
doi事实｜32例美容开鼻鼻整形3个月，PNIF 76.9→86.2，NOSE 23.4→14.3，鼻塞感略差。
点评｜功能没变差、反而改善；但客观气流与患者感受互不相关，别拿PNIF替病人说话。
In 32 aesthetic-only open rhinoplasties, PNIF rose from 76.9 to 86.2 L/min and NOSE fell from 23.4 to 14.3 at 3 months, though the nasal-fullness item worsened slightly. Airway function was preserved and even improved, but objective airflow and patient-reported scores did not correlate, so neither can stand in for the other.
鼻整形二次鼻整形肋软骨
Journal of Craniofacial Surgery · PMID 43001659 ·
doi事实｜20例鼻唇沟皮瓣后翻修，四段肋软骨支架经双侧鼻翼缘送入，12个月ROE 48.5→88.2。
点评｜瘢痕挛缩做不了常规开放式时，这条路走得通；单术者20例，只算可行，不算优选。
In 20 revision cases after nasolabial flap, a four-component rib scaffold delivered through bilateral alar rim incisions raised ROE from 48.5 to 88.2 at 12 months with no infection or extrusion. A workable route when scar contracture makes the standard open approach hazardous, but this single-surgeon series of 20 establishes feasibility, not superiority.
鼻整形耳软骨供区
Journal of Craniofacial Surgery · PMID 42980382 ·
doi事实｜92例耳软骨取材随访6–18个月：45例无畸形、41例轻度、6例明显未修、0例重度。
点评｜供区畸形能压到轻中度，但“轻度”占四成多；别跟病人保证耳朵外形一点不变。
Among 92 auricular cartilage harvests followed 6 to 18 months, 45 ears had no deformity, 41 mild deformity, 6 noticeable but unrevised, and none severe. Modified incision and harvest sites keep donor-site deformity mild at worst, but with 45% mild contour change, promise patients nothing better than that.
拉皮麻醉PONV
Research Square (preprint) · PMID ·
doi事实｜220例拉皮，96%用了地塞米松+昂丹司琼，仍62.3%发生恶心呕吐，49%呕吐，住院多9小时。
点评｜拉皮加眼睑、手术时间长，PONV风险明显升高；Apfel评分在这里不灵，双药预防不够。
In 220 facelifts with 96% receiving dexamethasone plus ondansetron, PONV still occurred in 62.3%, vomiting in 49%, and hospital stay was 9 hours longer. Concurrent blepharoplasty (OR 5.67) and longer operative time drove PONV while the Apfel score failed to predict it, so dual prophylaxis is not enough in combined long cases.
隆胸经脐入路系统综述
Aesthetic Plastic Surgery · PMID 42993310 ·
doi事实｜17项研究、6605人：经脐隆胸血肿0.2%、包膜挛缩1.7%、再干预2.3%，手术约60分钟。
点评｜数字漂亮，但几乎全是单臂回顾、随访短，只能证明“能做”，不能证明优于腋下或乳晕。
Across 17 studies and 6,605 patients, transumbilical augmentation showed pooled hematoma 0.2%, capsular contracture 1.7%, and reintervention 2.3%, with a median 60-minute operative time. The low complication rates come almost entirely from retrospective single-arm series with short follow-up, so they support feasibility, not equivalence to axillary or periareolar access.
隆胸假体长期随访
Aesthetic Surgery Journal · PMID 42987925 ·
doi事实｜5年挛缩率：解剖型0.31%、Xtra 1.42%、圆形5.16%；再手术3–5.5%。
点评｜0.31%不能读成解剖型更安全，研究没做头对头；但“五年约二十分之一再手术”可以拿去谈话。
At 5 years in primary augmentation, Baker III/IV contracture was 0.31% with MemoryShape, 1.42% with MemoryGel Xtra, and 5.16% with MemoryGel; reoperation for implant-related reasons was 2.9% to 5.5%. The study was not powered for device comparison, so the anatomical implant's 0.31% is not evidence of superiority; the 5-year reoperation rate near 1 in 20 is the number worth quoting.
还没有批注